查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678527

全球腫瘤消融市場：市場規模、佔有率、趨勢分析（按技術、治療方法、應用和地區）、細分市場預測（2025-2030 年）

Tumor Ablation Market Size, Share & Trends Analysis Report By Technology (Radiofrequency, Microwave), By Treatment (Surgical, Laparoscopic), By Application (Liver Cancer), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

腫瘤消融市場的成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，全球腫瘤消融市場規模預計到 2030 年將達到 40.8 億美元，預計 2025 年至 2030 年的複合年成長率為 13.8%。癌症發生率的增加和對有效治療方案的高需求是推動市場成長的主要因素。根據國際癌症研究機構的數據，2020 年報告了 19,292,789 例癌症病例，預計到 2025 年將達到 50,550,287 例。最常見的癌症是乳癌、肺癌、結腸癌、攝護腺癌和胃癌。由於微創手術具有恢復更快、患者更舒適、所需時間更短等優點，人們的偏好增加，預計將推動先進腫瘤消融手術的需求。

此外，此類設備與超音波、MRI 和 CT 等高效介入成像技術的結合有望徹底改變門診消融程序。預計這項轉變將大幅降低患者的費用，包括住院費用。政府資助的篩檢計劃、宣傳宣傳活動和特定癌症計劃等舉措預計將增加診斷病例的數量。例如，2019年，英國國家醫療服務體系（NHS）在部分地區啟動了肺癌篩檢計畫。這些舉措預計將增加對早期癌症管理的需求，從而推動市場成長。

腫瘤消融市場報告重點

  • 基於技術，射頻腫瘤消融領域將在 2024 年以 32.8% 的最大收入佔有率引領市場。
  • 按技術分類，經皮消融領域預計將在 2024 年佔據最大的收益佔有率。
  • 根據應用，其他部分在 2024 年佔據了最大的市場佔有率。其他部分包括各種類型的癌症，例如骨轉移和耳鼻喉癌。
  • 北美佔據腫瘤消融市場的主導地位，2024 年的收益佔有率最大，為 34.33%。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

3. 腫瘤消融市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 腫瘤消融市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析

第 4 章腫瘤消融市場：按技術分類的估計和趨勢分析

  • 定義和範圍
    • 射頻消融術
    • 微波消融
    • 冷凍療法
    • 不可逆電穿孔消融
    • HIFU
    • 其他消融技術
  • 按技術分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板
  • 全球腫瘤消融市場：技術展望
  • 市場規模預測及技術趨勢分析（2018-2030）
    • 射頻消融術
    • 微波消融
    • 冷凍療法
    • 不可逆電穿孔消融
    • HIFU
    • 其他消融技術

第 5 章腫瘤消融市場：按治療方法進行的估計和趨勢分析

  • 定義和範圍
    • 手術消融
    • 腹腔鏡消融術
    • 經經皮消融
  • 治療方法的市場佔有率（2024 年和 2030 年）
  • 細分儀表板
  • 全球腫瘤消融市場：治療方法視角
  • 市場規模預測及治療方法趨勢分析（2018-2030）
    • 手術消融
    • 腹腔鏡消融術
    • 經經皮消融

第6章腫瘤消融市場：應用估計與趨勢分析

  • 定義和範圍
    • 腎癌
    • 肝癌
    • 乳癌
    • 肺癌
    • 攝護腺癌
    • 其他癌症
  • 按應用分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板
  • 全球腫瘤消融市場：應用前景
  • 按應用分類的市場規模預測和趨勢分析（2018-2030 年）
    • 腎癌
    • 肝癌
    • 乳癌
    • 肺癌
    • 攝護腺癌
    • 其他癌症

第7章腫瘤消融市場：按地區估計和趨勢分析

  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 全球市場概況：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商概況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 主要企業市場佔有率分析（2024年）
    • Medtronic
    • Boston Scientific Corporation
    • Johnson &Johnson Service Inc.（Ethicon, Inc.）
    • AngioDynamics
    • Bioventus Inc.（Misonix Inc.）
    • EDAP TMS
    • Chongqing Haifu Medical Technology Co., Ltd
    • Mermaid Medical
    • HealthTronics, Inc.
    • HS Hospital Service SpA
Product Code: 978-1-68038-746-9

Tumor Ablation Market Growth & Trends:

The global tumor ablation market size is estimated to reach USD 4.08 billion by 2030, registering to grow at a CAGR of 13.8% from 2025 to 2030 according to a new report by Grand View Research, Inc. An increasing incidence of cancer and high demand for effective treatment options are the major factors contributing to market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020, and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported. The growing preference for minimally invasive procedures, attributed to advantages like fast recovery, patient comfort, and shorter turnaround times, is projected to drive demand for advanced tumor ablation techniques.

Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.

Tumor Ablation Market Report Highlights:

  • Based on technology, the radiofrequency tumor ablation segment led the market with the largest revenue share of 32.8% in 2024.
  • Based on technology, the percutaneous ablation segment accounted for the largest revenue share in 2024.
  • Based on application, the other segments accounted for the largest market share in 2024. The other segment includes various types of cancer, such as bone metastasis and ENT cancer.
  • North America dominated the tumor ablation market with the largest revenue share of 34.33% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Treatment
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Tumor Ablation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of cancer
      • 3.2.1.2. Technological advancements in ablation devices
      • 3.2.1.3. Increasing per capita income
      • 3.2.1.4. Growing demand of minimally invasive surgeries.
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
      • 3.2.2.2. Presence of alternative treatment options
  • 3.3. Tumor Ablation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Tumor Ablation Market: Technology Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Radiofrequency ablation
    • 4.1.2. Microwave ablation
    • 4.1.3. Cryoablation
    • 4.1.4. Irreversible electroporation ablation
    • 4.1.5. HIFU
    • 4.1.6. Other ablation technologies
  • 4.2. Technology Market Share, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Tumor Ablation Market by Technology Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Radiofrequency ablation
      • 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Microwave Ablation
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Cryoablation
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Irreversible electroporation ablation
      • 4.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.5. HIFU
      • 4.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.6. Other ablation technologies
      • 4.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Tumor Ablation Market: Treatment Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Surgical ablation
    • 5.1.2. Laparoscopic ablation
    • 5.1.3. Percutaneous ablation
  • 5.2. Treatment Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Tumor Ablation Market by Treatment Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Surgical ablation
      • 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Laparoscopic ablation
      • 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Percutaneous ablation
      • 5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Tumor Ablation Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Kidney cancer
    • 6.1.2. Liver cancer
    • 6.1.3. Breast cancer
    • 6.1.4. Lung cancer
    • 6.1.5. Prostate cancer
    • 6.1.6. Other cancer
  • 6.2. Application Market Share, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Tumor Ablation Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Kidney cancer
      • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 6.5.2. Liver cancer
      • 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Breast cancer
      • 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Lung cancer
      • 6.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Prostate cancer
      • 6.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Other cancer
      • 6.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Tumor Ablation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Medtronic
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Boston Scientific Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Johnson & Johnson Service Inc. (Ethicon, Inc.)
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. AngioDynamics
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Bioventus Inc. (Misonix Inc.)
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. EDAP TMS
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Chongqing Haifu Medical Technology Co., Ltd
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Mermaid Medical
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. HealthTronics, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. H.S. Hospital Service S.p.A.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 5 North America tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 U.S tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 10 Canada tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 Canada tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 13 Europe tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 14 Europe tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Europe tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 16 Europe tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 17 Germany tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 Germany tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 20 UK tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 22 UK tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 23 France tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 France tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 26 Italy tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 28 Italy tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 29 Spain tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Spain tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 32 Denmark tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 Denmark tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 35 Sweden tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 37 Sweden tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 38 Norway tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 40 Norway tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 45 China tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 47 China tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 48 Japan tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 50 Japan tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 51 India tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 53 India tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 54 South Korea tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Korea tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 56 South Korea tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 57 Australia tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 59 Australia tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 60 Thailand tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Thailand tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 62 Thailand tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 63 Latin America tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Latin America tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 65 Latin America surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 66 Latin America laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 69 Brazil tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 70 Brazil tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 71 Brazil surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 72 Brazil laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 73 Brazil percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 74 Brazil tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 75 Mexico tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 76 Mexico tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 77 Mexico surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 78 Mexico laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 79 Mexico percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 80 Mexico tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 81 Argentina tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 82 Argentina tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 83 Argentina surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 84 Argentina laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 85 Argentina percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 86 Argentina tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 87 MEA tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 88 MEA tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 89 MEA tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 90 MEA tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 91 South Africa tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 92 South Africa tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 93 South Africa tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 97 UAE tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 98 UAE tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 99 UAE tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 100 Kuwait tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Kuwait tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 102 Kuwait tumor ablation market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Tumor ablation market: market outlook
  • Fig. 14 Tumor ablation competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Tumor ablation market driver impact
  • Fig. 20 Tumor ablation market restraint impact
  • Fig. 21 Tumor ablation market strategic initiatives analysis
  • Fig. 22 Tumor ablation market: Technology movement analysis
  • Fig. 23 Tumor ablation market: Technology outlook and key takeaways
  • Fig. 24 Radiofrequency ablation market estimates and forecast, 2018 - 2030
  • Fig. 25 Microwave ablation estimates and forecast, 2018 - 2030
  • Fig. 26 Cryoablation market estimates and forecast, 2018 - 2030
  • Fig. 27 Irreversible electroporation ablation estimates and forecast, 2018 - 2030
  • Fig. 28 HIFU market estimates and forecast, 2018 - 2030
  • Fig. 29 Others estimates and forecast, 2018 - 2030
  • Fig. 30 Tumor ablation Market: Treatment Movement Analysis
  • Fig. 31 Tumor ablation market: Treatment outlook and key takeaways
  • Fig. 32 Surgical ablation market estimates and forecast, 2018 - 2030
  • Fig. 33 Percutaneous ablation market estimates and forecast, 2018 - 2030
  • Fig. 34 Laparoscopic ablation market estimates and forecast, 2018 - 2030
  • Fig. 35 Tumor ablation market: application movement analysis
  • Fig. 36 Tumor ablation market: application outlook and key takeaways
  • Fig. 37 Kidney cancer market estimates and forecast, 2018 - 2030
  • Fig. 38 Liver cancer market estimates and forecast, 2018 - 2030
  • Fig. 39 Breast cancer market estimates and forecast, 2018 - 2030
  • Fig. 40 Lung cancer market estimates and forecast, 2018 - 2030
  • Fig. 41 Prostate cancer market estimates and forecast, 2018 - 2030
  • Fig. 42 Other market estimates and forecast, 2018 - 2030
  • Fig. 43 Global tumor ablation market: Regional movement analysis
  • Fig. 44 Global tumor ablation market: Regional outlook and key takeaways
  • Fig. 45 Global tumor ablation market share and leading players
  • Fig. 46 North America market share and leading players
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Asia Pacific market share and leading players
  • Fig. 49 Latin America market share and leading players
  • Fig. 50 Middle East & Africa market share and leading players
  • Fig. 51 North America: SWOT
  • Fig. 52 Europe SWOT
  • Fig. 53 Asia Pacific SWOT
  • Fig. 54 Latin America SWOT
  • Fig. 55 MEA SWOT
  • Fig. 56 North America
  • Fig. 57 North America market estimates and forecast, 2018 - 2030
  • Fig. 58 US
  • Fig. 59 US market estimates and forecast, 2018 - 2030
  • Fig. 60 Canada
  • Fig. 61 Canada market estimates and forecast, 2018 - 2030
  • Fig. 62 Europe
  • Fig. 63 Europe market estimates and forecast, 2018 - 2030
  • Fig. 64 UK
  • Fig. 65 UK market estimates and forecast, 2018 - 2030
  • Fig. 66 Germany
  • Fig. 67 Germany market estimates and forecast, 2018 - 2030
  • Fig. 68 France
  • Fig. 69 France market estimates and forecast, 2018 - 2030
  • Fig. 70 Italy
  • Fig. 71 Italy market estimates and forecast, 2018 - 2030
  • Fig. 72 Spain
  • Fig. 73 Spain market estimates and forecast, 2018 - 2030
  • Fig. 74 Denmark
  • Fig. 75 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 76 Sweden
  • Fig. 77 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 78 Norway
  • Fig. 79 Norway market estimates and forecast, 2018 - 2030
  • Fig. 80 Asia Pacific
  • Fig. 81 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 82 China
  • Fig. 83 China market estimates and forecast, 2018 - 2030
  • Fig. 84 Japan
  • Fig. 85 Japan market estimates and forecast, 2018 - 2030
  • Fig. 86 India
  • Fig. 87 India market estimates and forecast, 2018 - 2030
  • Fig. 88 Thailand
  • Fig. 89 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 90 South Korea
  • Fig. 91 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 92 Australia
  • Fig. 93 Australia market estimates and forecast, 2018 - 2030
  • Fig. 94 Latin America
  • Fig. 95 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 96 Brazil
  • Fig. 97 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 98 Mexico
  • Fig. 99 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 100 Argentina
  • Fig. 101 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 102 Middle East and Africa
  • Fig. 103 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 104 South Africa
  • Fig. 105 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 106 Saudi Arabia
  • Fig. 107 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 108 UAE
  • Fig. 109 UAE market estimates and forecast, 2018 - 2030
  • Fig. 110 Kuwait
  • Fig. 111 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 112 Market share of key market players - Tumor ablation market